BSGM: the balance sheet

MyFinsight

For the quarter ending 2025-06-30, BSGM has $109,700K in assets. $113,200K in debts.

Balance Sheets Overview

Debt to Asset Ratio
103.19%
Assets Breakdown
Total assets
Liabilities Breakdown
Accumulated deficit
Additional paid-in-capital
Derivative liability
Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-06-30
Total assets	109,700

Accounts payable and accrued expenses, including 466 and 19 to related parties as of june 30, 2025 and december 31, 2024, respectively	7,572
Lease liability, short term	15
Dividends payable	115
Derivative liability	105,498
Total current liabilities	113,200
Total liabilities	113,200
Accumulated deficit	-278,529
Common stock, 0.001 par value, authorized 200,000,000 shares, 30,793,135 and 17,239,096 issued and outstanding as of june 30, 2025 and december 31, 2024, respectively	31
Additional paid-in-capital	273,343
Accumulated other comprehensive income	1,538
Total stockholders deficit attributable to biosig technologies, inc	-3,617
Non-controlling interest	33
Total stockholders deficit	-3,584
Redeemable series c 9 convertible preferred stock, 0.001 par value, 1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding (liquidation preference of 105 cumulative dividends payable of 115 and 110 as of june 30, 2025 and december 31, 2024, respectively)	105
Total liabilities, mezzanine equity and stockholders deficit	109,721

Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets